LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 108.0 | 481.2 | 32.8 | 0.6 | - | 622.6 |
1 | - | - | - | - | - | 59.6 | 213.6 | 5.6 | - | - | 278.8 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 6.0 |
1 | 1.4 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | - |
1 | - |
Number of post synapses: 3113
Number of pre synapses: 1394
Number of output connections: 4758
Coverage factor: 1.5
Columnar completeness: 0.57
Area completeness: 0.72
Cell size (columns): 111
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#Cm24 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Cm6 (R) | GABA | 358 | 71.6 | 11.6% | 11.6% |
1 | Cm7 (R) | Glu | 214 | 42.8 | 7.0% | 18.6% |
2 | MeVC2 (L) | ACh | 207 | 41.4 | 6.7% | 25.3% |
3 | MeVPMe4 (L) | Glu | 170 | 34.0 | 5.5% | 30.9% |
4 | MeVC4a (L) | ACh | 164 | 32.8 | 5.3% | 36.2% |
5 | MeLo6 (R) | ACh | 144 | 28.8 | 4.7% | 40.9% |
6 | Cm16 (R) | Glu | 143 | 28.6 | 4.6% | 45.5% |
7 | Cm20 (R) | GABA | 139 | 27.8 | 4.5% | 50.0% |
8 | MeLo3b (R) | ACh | 109 | 21.8 | 3.5% | 53.6% |
9 | Cm34 (R) | Glu | 90 | 18.0 | 2.9% | 56.5% |
10 | MeVP29 (R) | ACh | 88 | 17.6 | 2.9% | 59.4% |
11 | Mi10 (R) | ACh | 74 | 14.8 | 2.4% | 61.8% |
12 | MeTu4b (R) | ACh | 73 | 14.6 | 2.4% | 64.1% |
13 | MeLo1 (R) | ACh | 66 | 13.2 | 2.1% | 66.3% |
14 | MeTu4e (R) | ACh | 63 | 12.6 | 2.0% | 68.3% |
15 | MeVP1 (R) | ACh | 63 | 12.6 | 2.0% | 70.4% |
16 | MeVC3 (L) | ACh | 62 | 12.4 | 2.0% | 72.4% |
17 | MeVPMe11 (L) | Glu | 42 | 8.4 | 1.4% | 73.8% |
18 | Cm12 (R) | GABA | 39 | 7.8 | 1.3% | 75.0% |
19 | Mi15 (R) | ACh | 38 | 7.6 | 1.2% | 76.3% |
20 | Tm37 (R) | Glu | 34 | 6.8 | 1.1% | 77.4% |
21 | MeVP16 (R) | Glu | 31 | 6.2 | 1.0% | 78.4% |
22 | TmY10 (R) | ACh | 31 | 6.2 | 1.0% | 79.4% |
23 | MeVP6 (R) | Glu | 27 | 5.4 | 0.9% | 80.3% |
24 | MeTu4a (R) | ACh | 24 | 4.8 | 0.8% | 81.0% |
25 | Dm2 (R) | ACh | 20 | 4.0 | 0.7% | 81.7% |
26 | MeVP62 (R) | ACh | 20 | 4.0 | 0.7% | 82.3% |
27 | MeVC11 (L) | ACh | 19 | 3.8 | 0.6% | 83.0% |
28 | MeTu3b (R) | ACh | 18 | 3.6 | 0.6% | 83.6% |
29 | MeVP3 (R) | ACh | 17 | 3.4 | 0.6% | 84.1% |
30 | MeVPMe3 (L) | Glu | 17 | 3.4 | 0.6% | 84.7% |
31 | Tm34 (R) | Glu | 17 | 3.4 | 0.6% | 85.2% |
32 | MeVC4b (L) | ACh | 16 | 3.2 | 0.5% | 85.7% |
33 | MeVPaMe1 (R) | ACh | 16 | 3.2 | 0.5% | 86.2% |
34 | Tm39 (R) | ACh | 16 | 3.2 | 0.5% | 86.8% |
35 | Cm8 (R) | GABA | 15 | 3.0 | 0.5% | 87.3% |
36 | MeVC27 (L) | unclear | 15 | 3.0 | 0.5% | 87.7% |
37 | aMe5 (R) | ACh | 14 | 2.8 | 0.5% | 88.2% |
38 | Cm28 (R) | unclear | 12 | 2.4 | 0.4% | 88.6% |
39 | MeTu4c (R) | ACh | 12 | 2.4 | 0.4% | 89.0% |
40 | aMe9 (R) | ACh | 11 | 2.2 | 0.4% | 89.3% |
41 | Cm4 (R) | Glu | 10 | 2.0 | 0.3% | 89.7% |
42 | MeTu1 (R) | ACh | 10 | 2.0 | 0.3% | 90.0% |
43 | MeVP10 (R) | ACh | 10 | 2.0 | 0.3% | 90.3% |
44 | aMe10 (R) | ACh | 9 | 1.8 | 0.3% | 90.6% |
45 | aMe10 (L) | ACh | 9 | 1.8 | 0.3% | 90.9% |
46 | MeTu2a (R) | ACh | 9 | 1.8 | 0.3% | 91.2% |
47 | MeTu3c (R) | ACh | 9 | 1.8 | 0.3% | 91.5% |
48 | MeVC24 (R) | Glu | 9 | 1.8 | 0.3% | 91.8% |
49 | Cm24 (R) | Glu | 8 | 1.6 | 0.3% | 92.0% |
50 | Cm5 (R) | GABA | 8 | 1.6 | 0.3% | 92.3% |
51 | MeVC7b (L) | ACh | 8 | 1.6 | 0.3% | 92.6% |
52 | MeVP11 (R) | ACh | 8 | 1.6 | 0.3% | 92.8% |
53 | MeVP45 (R) | ACh | 8 | 1.6 | 0.3% | 93.1% |
54 | OA-AL2i4 (R) | OA | 8 | 1.6 | 0.3% | 93.3% |
55 | Pm12 (R) | Glu | 8 | 1.6 | 0.3% | 93.6% |
56 | 5-HTPMPV03 (R) | 5HT | 7 | 1.4 | 0.2% | 93.8% |
57 | Cm21 (R) | GABA | 7 | 1.4 | 0.2% | 94.1% |
58 | Cm3 (R) | GABA | 7 | 1.4 | 0.2% | 94.3% |
59 | Pm8 (R) | GABA | 7 | 1.4 | 0.2% | 94.5% |
60 | 5-HTPMPV03 (L) | 5HT | 6 | 1.2 | 0.2% | 94.7% |
61 | Cm10 (R) | GABA | 6 | 1.2 | 0.2% | 94.9% |
62 | MeVP14 (R) | ACh | 6 | 1.2 | 0.2% | 95.1% |
63 | MeVP32 (R) | ACh | 6 | 1.2 | 0.2% | 95.3% |
64 | MeVP59 (R) | ACh | 6 | 1.2 | 0.2% | 95.5% |
65 | MeTu3a (R) | ACh | 5 | 1.0 | 0.2% | 95.6% |
66 | MeVC21 (R) | Glu | 5 | 1.0 | 0.2% | 95.8% |
67 | MeVP21 (R) | ACh | 5 | 1.0 | 0.2% | 96.0% |
68 | TmY21 (R) | ACh | 5 | 1.0 | 0.2% | 96.1% |
instance | NT | total connections | connections /#Cm24 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Cm3 (R) | GABA | 1,263 | 252.6 | 26.4% | 26.4% |
1 | Cm12 (R) | GABA | 533 | 106.6 | 11.2% | 37.6% |
2 | Cm8 (R) | GABA | 347 | 69.4 | 7.3% | 44.8% |
3 | MeLo6 (R) | ACh | 318 | 63.6 | 6.7% | 51.5% |
4 | Cm30 (R) | GABA | 224 | 44.8 | 4.7% | 56.2% |
5 | Cm34 (R) | Glu | 207 | 41.4 | 4.3% | 60.5% |
6 | MeLo3b (R) | ACh | 166 | 33.2 | 3.5% | 64.0% |
7 | Cm5 (R) | GABA | 160 | 32.0 | 3.3% | 67.3% |
8 | MeVP6 (R) | Glu | 130 | 26.0 | 2.7% | 70.0% |
9 | Cm21 (R) | GABA | 112 | 22.4 | 2.3% | 72.4% |
10 | MeVP45 (R) | ACh | 98 | 19.6 | 2.1% | 74.4% |
11 | aMe9 (R) | ACh | 86 | 17.2 | 1.8% | 76.2% |
12 | Cm31b (R) | GABA | 74 | 14.8 | 1.5% | 77.8% |
13 | aMe26 (R) | ACh | 72 | 14.4 | 1.5% | 79.3% |
14 | MeTu4a (R) | ACh | 66 | 13.2 | 1.4% | 80.7% |
15 | Cm20 (R) | GABA | 49 | 9.8 | 1.0% | 81.7% |
16 | Cm4 (R) | Glu | 43 | 8.6 | 0.9% | 82.6% |
17 | Cm7 (R) | Glu | 43 | 8.6 | 0.9% | 83.5% |
18 | OA-AL2i4 (R) | OA | 42 | 8.4 | 0.9% | 84.4% |
19 | TmY10 (R) | ACh | 39 | 7.8 | 0.8% | 85.2% |
20 | MeVC2 (L) | ACh | 38 | 7.6 | 0.8% | 86.0% |
21 | Mi16 (R) | GABA | 36 | 7.2 | 0.8% | 86.7% |
22 | LT88 (R) | Glu | 35 | 7.0 | 0.7% | 87.5% |
23 | Mi14 (R) | Glu | 33 | 6.6 | 0.7% | 88.2% |
24 | Cm6 (R) | GABA | 23 | 4.6 | 0.5% | 88.6% |
25 | MeVP1 (R) | ACh | 22 | 4.4 | 0.5% | 89.1% |
26 | MeTu4b (R) | ACh | 21 | 4.2 | 0.4% | 89.5% |
27 | Cm14 (R) | GABA | 20 | 4.0 | 0.4% | 90.0% |
28 | Cm16 (R) | Glu | 20 | 4.0 | 0.4% | 90.4% |
29 | TmY21 (R) | ACh | 19 | 3.8 | 0.4% | 90.8% |
30 | MeVC20 (R) | Glu | 17 | 3.4 | 0.4% | 91.1% |
31 | MeVP14 (R) | ACh | 17 | 3.4 | 0.4% | 91.5% |
32 | MeVP43 (R) | ACh | 17 | 3.4 | 0.4% | 91.8% |
33 | MeVPMe8 (R) | Glu | 17 | 3.4 | 0.4% | 92.2% |
34 | Tm40 (R) | ACh | 17 | 3.4 | 0.4% | 92.6% |
35 | MeVC4a (L) | ACh | 14 | 2.8 | 0.3% | 92.8% |
36 | Cm35 (R) | GABA | 12 | 2.4 | 0.3% | 93.1% |
37 | MeVPMe11 (R) | Glu | 12 | 2.4 | 0.3% | 93.3% |
38 | Mi17 (R) | GABA | 12 | 2.4 | 0.3% | 93.6% |
39 | MeTu1 (R) | ACh | 10 | 2.0 | 0.2% | 93.8% |
40 | MeTu3c (R) | ACh | 10 | 2.0 | 0.2% | 94.0% |
41 | Tm39 (R) | ACh | 10 | 2.0 | 0.2% | 94.2% |
42 | Dm2 (R) | ACh | 9 | 1.8 | 0.2% | 94.4% |
43 | Lat3 (R) | unclear | 9 | 1.8 | 0.2% | 94.6% |
44 | Cm24 (R) | Glu | 8 | 1.6 | 0.2% | 94.8% |
45 | MeVP21 (R) | ACh | 8 | 1.6 | 0.2% | 94.9% |
46 | Tm34 (R) | Glu | 8 | 1.6 | 0.2% | 95.1% |
47 | Mi10 (R) | ACh | 7 | 1.4 | 0.1% | 95.3% |
48 | Y14 (R) | Glu | 7 | 1.4 | 0.1% | 95.4% |
49 | MeTu3b (R) | ACh | 6 | 1.2 | 0.1% | 95.5% |
50 | MeTu4c (R) | ACh | 6 | 1.2 | 0.1% | 95.6% |
51 | MeVP10 (R) | ACh | 6 | 1.2 | 0.1% | 95.8% |
52 | MeVP11 (R) | ACh | 6 | 1.2 | 0.1% | 95.9% |
53 | MeVP18 (R) | unclear | 6 | 1.2 | 0.1% | 96.0% |
54 | MeVP46 (R) | Glu | 6 | 1.2 | 0.1% | 96.2% |
55 | MeVP49 (R) | unclear | 6 | 1.2 | 0.1% | 96.3% |
56 | MeVPLp2 (R) | Glu | 6 | 1.2 | 0.1% | 96.4% |
57 | MeVPMe5 (R) | Glu | 6 | 1.2 | 0.1% | 96.5% |
58 | Tm36 (R) | ACh | 6 | 1.2 | 0.1% | 96.7% |
59 | Cm10 (R) | GABA | 5 | 1.0 | 0.1% | 96.8% |